Detalhe da pesquisa
1.
Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
J Virol
; 91(3)2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795412
2.
Delineation of pulmonary airway fluid protein fractions with HRPO binding-avidity by far-Western ligand blot and mass spectrometry analyses: a model methodology for detecting mannose-binding protein expression profiles.
Acta Biomed
; 80(3): 243-61, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20578419
3.
Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549).
Anticancer Agents Med Chem
; 19(6): 802-819, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514195
4.
Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Stage Regimen.
Curr Pharm Des
; 24(11): 1224-1240, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29141539
5.
Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549).
Chem Biol Drug Des
; 89(3): 379-399, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27561602
6.
Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).
Drug Des Devel Ther
; 10: 2575-97, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27574398
7.
Factors associated with amount of research funding obtained from the National Institutes of Health by colleges and schools of veterinary medicine.
Am J Vet Res
; 69(12): 1676-86, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19046018
8.
Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.
Cancer Biother Radiopharm
; 27(1): 41-55, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22191802
9.
Synthesis of Gemcitabine-(C4-amide)-[anti-HER2/neu] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3.
J Cancer Ther
; 3(5A): 689-711, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26225216
10.
Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium.
J Cancer Ther
; 2(1): 22-39, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26229727